Oxford University advances its multi-stage malaria vaccine through an expanded partnership with India's Serum Institute, integrating the R78C candidate with existing components.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Oxford University reaches milestone in new malaria vaccine | This is Oxfordshire
Hundreds Of Millions cases Cases reported annually
Children In Sub-Saharan Africa Primary affected population
Multi-Stage Candidate With R78C Integration Vaccine development stage
Sub-Saharan Africa primary region affected